Posted in | News | New Product

Bruker Introduces eWARP, a Pioneering New EBSD Detector for Advanced Materials Characterization in Scanning Electron Microscopes

BERLIN, Germany – March 26th, 2025 – Today, Bruker announces the launch of eWARP, a groundbreaking new detector for Electron Backscatter Diffraction (EBSD) that marks the advent of a new era in EBSD technology. Featuring a revolutionary Bruker-engineered camera that combines direct electron detection and CMOS technologies, the new eWARP (Wide ARea Pixelated sensor) is the fastest and most signal efficient EBSD detector ever, significantly pushing the limits for materials characterization in Scanning Electron Microscopes (SEM).

Unlike other EBSD detectors in the market that are utilizing off-the-shelf sensors for direct electron detection, eWARP’s hybrid pixel sensor and high-speed signal-processing electronics have been designed using a first principles approach, with EBSD-specific requirements in mind. As a result, eWARP vastly outperforms existing solutions, especially in terms of signal efficiency and acquisition speed, providing users with game-changing new analytical opportunities.

​​​​​​​

The world’s fastest and most signal efficient EBSD detector.

Image Credit: Bruker Nano Analytics


Combined with our ESPRIT software suite, eWARP enables the acquisition of EBSD maps with up to 14,400 patterns per second at electron beam settings as low as 10 kV accelerating voltage and 12 nA probe current. At the core of eWARP sits the patented first ever CMOS device with on-sensor binning capability. When operated in binning mode, the sensor performs Forescatter Electron (FSE) and Backscatter Electron (BSE) imaging with up to 350,000 patterns per second.

This quantum leap in performance will have a transformational impact on the future potential of the EBSD technique, especially when it comes to challenging applications for which high spatial resolution, low electron energy and/or short exposure time are critically important. For instance,

  • automated acquisition of 3D EBSD data can now be done in much less time, at higher pixel resolution or covering a larger volume,
  • the characterization of ultra-fine grained or heavily deformed materials will greatly benefit from spatial resolution improvements down to 20 nm while still operating at ultra-high speed,
  • time-resolved EBSD mapping, i.e. the acquisition of repetitive maps and images every few seconds, will become feasible, helping to understand microstructural changes inside materials during in-situ heating and/or mechanical testing experiments.

Beyond its superior analytical performance, eWARP’s revolutionary design also guarantees minimized cost of ownership and maximized uptime due to remote detector monitoring for preventive/predictive maintenance, the field-replaceable camera module and user upgradable firmware for future performance and functionality improvements.

"We are so excited to introduce the eWARP, a new product that embodies our dedication to innovation and excellence," said Dr. Daniel Goran, Senior Product Manager EBSD at Bruker. "Enabling entirely new levels of performance in terms of data acquisition, we are confident the resulting new analytical capabilities and higher productivity will help to significantly further increase the adoption of the EBSD technique in academia and industry."

For more information about the eWARP, please visit www.bruker.com/eWARP

About Bruker Corporation – Leader of the Post-Genomic Era

Bruker is enabling scientists and engineers to make breakthrough post-genomic discoveries and develop new applications that improve the quality of human life. Bruker’s high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity, and customer success in post-genomic life science molecular and cell biology research, in applied and biopharma applications, in microscopy and nanoanalysis, as well as in industrial and cleantech research, and next-gen semiconductor metrology in support of AI and HPC. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit www.bruker.com.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Bruker Nano Analytics. (2025, March 28). Bruker Introduces eWARP, a Pioneering New EBSD Detector for Advanced Materials Characterization in Scanning Electron Microscopes. AZoM. Retrieved on March 31, 2025 from https://www.azom.com/news.aspx?newsID=64406.

  • MLA

    Bruker Nano Analytics. "Bruker Introduces eWARP, a Pioneering New EBSD Detector for Advanced Materials Characterization in Scanning Electron Microscopes". AZoM. 31 March 2025. <https://www.azom.com/news.aspx?newsID=64406>.

  • Chicago

    Bruker Nano Analytics. "Bruker Introduces eWARP, a Pioneering New EBSD Detector for Advanced Materials Characterization in Scanning Electron Microscopes". AZoM. https://www.azom.com/news.aspx?newsID=64406. (accessed March 31, 2025).

  • Harvard

    Bruker Nano Analytics. 2025. Bruker Introduces eWARP, a Pioneering New EBSD Detector for Advanced Materials Characterization in Scanning Electron Microscopes. AZoM, viewed 31 March 2025, https://www.azom.com/news.aspx?newsID=64406.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.